Chemoradiotherapy-exposed TIMEs were highly enriched with newly infiltrated tumor-specific CD8+ T cells and tissue-resident memory T cells, moreover, the authors found that chemoradiotherapy combined with dual CTLA-4 and PD-1 blockade achieved optimal anti-tumor effects (254). The gene discussed is CD8A; the disease is neoplasm.